BioSpace News Archive

American Psychedelic Practitioners Association (APPA) has announced the appointment of Brigadier General (Ret.) Stephen N. Xenakis, MD as new Executive Director of the organization.

NLS Pharmaceutics Ltd. today announced plans to showcase its global strategic R&D progress and platform.

NLS Pharmaceutics Ltd. today announced that Alex Zwyer, Chief Executive Officer of NLS Pharmaceutics will present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20, 2023, at 10:30 AM ET.

Omicsveu is committed to advance the pace of Spatial Biology research through yet another achievement, automating RNAscopeTM manual protocol with NanoVIP® All-in-One autostainer.

FemAid, A pioneering Medical Devise company dedicated to empowering woman’s health, is pleased to announce a major achievement in the development of its groundbreaking prototyping phase and patent filing application, marking a significant step towards revolutionizing the management of urinary incontinence in women.

Conference hosted by M-Vest, Awakn to present on Thursday, June 22nd at 9:00 A.M. ET

Diabetes is among the top ten leading causes of death in the United States, with more than 1.4 million new cases diagnosed each year.

Quest collaborated with Coriell Life Sciences to offer select medical plan members pharmacogenomics testing services indicating how specific genes and their variations impact a person’s response to medications.

Curocell Inc, a Korea-based clinical-stage CAR-T cell therapy company, announced updated Phase 2 interim results for Anbalcabtagene-autoleucel (anbal-cel) on June 15, 2023, at ICML (International Conference on Malignant Lymphoma), Lugano, Switzerland.

Arcellx, Inc. (NASDAQ: ACLX) announced today that it has received notification from the U.S. Food and Drug Administration (FDA) that a clinical hold has been placed on its CART-ddBCMA investigational new drug (IND) for the treatment of patients with relapsed or refractory multiple myeloma (rrMM).